Two federal agencies are investigating the drug maker Merck related to antibribery laws, the company acknowledged on Monday.
Merck, one of the world’s largest drug companies by revenue, said in a regulatory filing on Friday that it had received inquiry letters from the Justice Department and the Securities and Exchange Commission. The letters “seek information about activities in a number of countries and reference the Foreign Corrupt Practices Act,” according to Merck.
via Merck Is Subject of U.S. Bribery Inquiries – NYTimes.com.
